Trial Profile
Comparison of basal insulin peglispro and insulin glargine in terms of endogenous glucose production, glucose disposal rate and lipolysis in patients with type 1 diabetes: A randomised, open-label, four-period crossover study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2017
Price :
$35
*
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 20 Nov 2017 New trial record